OSUR · NASDAQ · Medical - Instruments & Supplies

OraSure Technologies (OSUR)

Makes OraQuick tests and sample-management devices for decentralized diagnostics.

$3.93
After hours−0.06 (−1.50%)
At close$3.99(+8.13%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue897654544037303127272831
Cost of revenue454030292324181815161717
Gross profit443624261714121312111013
27282826232531302728348
Research & development97866610111011139
192120191719211916192021
Selling & marketing000000766707
General & administrative00000014131012014
Other expenses000000001−30−23
Operating income178−30−6−12−18−17−16−17−235
−4130022202−201
Other non-operating income0−1300−2−2−20−2201
Income before tax1421−40−4−10−16−18−14−19−237
Income tax expense210011020001
Net income from continuing operations1120−4−1−5−11−16−20−14−19−226
Net income1120−4−1−5−11−16−20−14−19−226
EPS, basic$0.15$0.27−$0.05−$0.01−$0.06−$0.14−$0.21−$0.26−$0.19−$0.27−$0.32$0.09
EPS, diluted$0.15$0.27−$0.05−$0.01−$0.06−$0.14−$0.21−$0.26−$0.19−$0.27−$0.32$0.09
Weighted average shares, basic737374747574757573727069
Weighted average shares, diluted747574747574757573727070
EBITDA2024−12−1−10−14−15−11−17−204
Depreciation & amortization343330322220
EBIT1721−40−4−10−16−18−14−19−234